PepGen Inc

PEPG NASDAQ Santé & Biotech États-Unis US7133171055
1.39 $
0.10 %

PepGen Inc développe des traitements destinés aux maladies neuromusculaires rares.

Performance & Momentum

6 Months 74.78 %
1 Year 6.00 %
3 Years 91.33 %
5 Years 89.06 %

Similar stocks to PepGen Inc

Anantys Community

Be the first to share your analysis on PepGen Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases